Document is current
Any future updates will be listed below
-
Authors
Du, Xinwen
Huang, Xuan
Feng, Xianqiong
Shui, Yuping
Zhang, Aihua
Li, Jialing
Qiu, Chujin
Wang, Guan
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr1800016713 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
The effects of the-optimal-lymph-flow health IT system application on treatment-related high risk lymphedema in breast cancer patients: a randomized controlled trial
https://doi.org/10.1007/s10549-024-07468-7
-
Funding
Funding for this research was provided by:
Sichuan Province Science and Technology Development Funds (2019YFS0295)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 13 August 2024
First Online: 23 August 2024
Declarations
:
: The authors declare no conflict of interest.
: This study was approved by the Medical Ethics Committee of the study Hospital, Sichuan University (2019/24). The registration number in ClinicalTrials.gov is ChiCTR1800016713.
